Kabra Drugs Ltd

Kabra Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kabra Drugs Ltd

₹ 20.9 3.67%
10 Sep 9:45 a.m.
kabradrugs.com BSE: 524322
About

Incorporated in 1989, Kabra Drugs Ltd deals in pharmaceutical products, biological API’s and biochemicals.[1]

Key Points

Business Overview:[1]
KDL is in the business of manufacturing Perma
culture and trading in the pharma-related product.

Website BSE
  • Market Cap ₹ 49.6 Cr.
  • Current Price ₹ 20.9
  • High / Low ₹ 22.8 / 9.14
  • Stock P/E
  • Book Value ₹ 10.4
  • Dividend Yield 0.00 %
  • ROCE -7.82 %
  • ROE -8.47 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.15
0.07 0.07 0.06 0.14 0.12 0.13 0.11 0.37 0.55 0.40 0.53 0.24 7.67
Operating Profit -0.07 -0.07 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.53 -0.24 -0.52
OPM % -7.27%
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.64 0.02
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Profit before tax -0.07 -0.06 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.53 0.39 -0.50
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.07 -0.06 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40 -0.54 0.39 -0.50
EPS in Rs -0.16 -0.14 -0.14 -0.32 -0.27 -0.30 -0.25 -0.84 -1.25 -0.40 -0.54 0.16 -0.21
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
11.42 8.24 9.59 7.61 1.81 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 7.15
10.84 7.77 9.14 7.17 2.84 0.09 0.05 0.15 0.18 0.35 0.74 1.72 8.84
Operating Profit 0.58 0.47 0.45 0.44 -1.03 -0.13 -0.05 -0.15 -0.18 -0.35 -0.74 -1.72 -1.69
OPM % 5.08% 5.70% 4.69% 5.78% -56.91% -150.00% -3,400.00% -23.64%
-0.03 0.01 0.02 0.11 -0.94 0.01 0.02 0.00 0.00 0.01 0.00 0.64 0.66
Interest 0.07 0.14 0.18 0.17 0.25 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.26 0.23 0.24 0.24 0.14 0.03 0.03 0.03 0.01 0.00 0.00 0.01 0.01
Profit before tax 0.22 0.11 0.05 0.14 -2.36 -0.16 -0.06 -0.18 -0.19 -0.34 -0.74 -1.09 -1.04
Tax % 59.09% 36.36% 40.00% 7.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.09 0.07 0.03 0.13 -2.36 -0.16 -0.06 -0.18 -0.19 -0.34 -0.74 -1.09 -1.05
EPS in Rs 0.21 0.16 0.07 0.30 -5.38 -0.36 -0.14 -0.41 -0.43 -0.77 -1.69 -0.46 -0.99
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Stock Price CAGR
10 Years: 7%
5 Years: 49%
3 Years: 55%
1 Year: 131%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -8%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 23.71
Reserves -1.46 -1.78 -1.76 -1.84 -4.19 -4.36 -4.42 -4.60 -4.78 -5.12 -3.31 0.95
3.01 2.81 2.39 1.80 0.70 0.67 0.65 0.90 1.03 1.38 1.71 0.44
3.27 3.12 4.15 2.03 0.80 0.78 0.79 0.71 0.09 0.05 1.78 0.13
Total Liabilities 9.21 8.54 9.17 6.38 1.70 1.48 1.41 1.40 0.73 0.70 4.57 25.23
3.30 2.78 2.73 2.48 0.11 0.08 0.04 0.01 0.00 0.00 0.00 0.04
CWIP 0.00 0.10 0.21 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5.91 5.66 6.23 3.69 1.59 1.40 1.37 1.39 0.73 0.70 4.57 25.19
Total Assets 9.21 8.54 9.17 6.38 1.70 1.48 1.41 1.40 0.73 0.70 4.57 25.23

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 -0.22 0.28 0.31 -0.12 -0.18 -0.05 -0.25 -0.13 -0.35 -0.21 -4.71
-0.14 -0.20 -0.29 0.01 1.50 0.07 0.06 0.00 0.00 0.00 0.00 -0.05
0.14 0.58 -0.27 -0.32 -1.35 0.00 -0.02 0.25 0.13 0.36 2.88 23.39
Net Cash Flow 0.00 0.16 -0.28 0.00 0.04 -0.10 0.00 0.00 -0.01 0.00 2.67 18.63

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 146.38 198.00 204.00 141.49 254.09 -11,406.25
Inventory Days 31.67 25.58 16.04 16.73 0.00 0.00
Days Payable 79.17 129.78 139.88 97.33
Cash Conversion Cycle 98.88 93.81 80.16 60.89 254.09 -11,406.25
Working Capital Days 52.10 85.93 69.65 34.05 -28.23 -912.50
ROCE % 5.52% 4.40% 4.41% 6.62% -44.19% -18.75% -9.09% -27.48% -28.57% -52.71% -43.02% -7.82%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
99.99% 100.00% 100.01% 100.01% 100.01% 100.01% 100.01% 100.01% 100.01% 100.00% 100.00% 100.01%
No. of Shareholders 7,4037,4017,4247,4207,4157,3967,3647,3367,3677,3437,4357,449

Documents

Announcements

Annual reports